Publications by authors named "Bree Ann C Young"
Article Synopsis
- Venovenous extracorporeal membrane oxygenation (VV ECMO) has been used to treat severe COVID-19 patients, but criteria for choosing candidates have changed during the pandemic.
- This study aimed to find out if the time from a positive COVID-19 test or infiltrates seen on chest X-rays to the initiation of VV ECMO affects patient mortality rates.
- Results indicated that a longer time from chest X-ray infiltrate to ECMO cannulation was associated with higher mortality, while the time from a positive test had less impact on survival. Further studies are needed for confirmation.
Introduction: With the increased demand for veno-venous extracorporeal membrane oxygenation (VV ECMO) during the COVID-19 pandemic, guidelines for patient candidacy have often limited this modality for patients with a body mass index (BMI) less than 40 kg/m. We hypothesize that COVID-19 VV ECMO patients with at least class III obesity (BMI ≥ 40) have decreased in-hospital mortality when compared to non-COVID-19 and non-class III obese COVID-19 VV ECMO populations.
Methods: This is a single-center retrospective study of COVID-19 VV ECMO patients from January 1, 2014, to November 30, 2021.
Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?
J Thorac Cardiovasc Surg
March 2023
SIPAT score components seem useful in evaluating psychosocial support for LVAD candidacy. However, a focused LVAD psychosocial score may be more relevant given distinct challenges.
View Article and Find Full Text PDFThe COVID-19 pandemic has had significant ramifications for provider well-being. During these unprecedented and challenging times, one institution's Department of Surgery put in place several important initiatives for promoting the well-being of trainees as they were redeployed to provide care to COVID-19 patients. In this article, the authors describe these initiatives, which fall into 3 broad categories: redeploying faculty and trainees, ensuring provider safety, and promoting trainee wellness.
View Article and Find Full Text PDFBackground: Although liver disease increases surgical risk, it is not considered in The Society for Thoracic Surgeons (STS) risk calculator. This study assessed the impact of Model for End-Stage Liver Disease (MELD) on outcomes after cardiac surgical procedures and the additional predictive value of MELD in the STS risk model.
Methods: Deidentified records of 21,272 patients were extracted from a regional STS database.